X T L Bio

XTLB NASDAQ
1.980
0.000
0.00%
Closed 16:00 07/16 EDT
Open
--
Prev Close
1.980
High
--
Low
--
Volume
--
Avg Vol (3M)
1.64K
52 Week High
3.855
52 Week Low
1.430
% Turnover
0%
Market Cap
9.06M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers X T L Bio XTLB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
MORE >

Recently

Name
Price
%Change